Recently, a CD8+ T-cell reactivity against KRASG12D has been detected in tumor-infiltrating lymphocytes (TILs) from a patient with metastatic colon cancer, which could recognize and kill tumors in an HLA-C*08:02-restricted, KRASG12D-specific manner [82]. This evidence concerns the gene CD8A and neoplasm.